Oral

Influence of Oral Vitamin D3 on Chronic Rhinosinusitis With Nasal Polyposis Patients and Lower Vitamin D Levels

Condition:   Chronic Rhinosinusitis With Nasal PolypsInterventions:   Drug: Vitamin D;   Drug: Budesonide Nasal Spray;   Other: placeboSponsor:   The First Affiliated Hospital of Shanxi Medical UniversityNot yet recruiting – verified January 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)

Condition:   Peanut AllergyInterventions:   Biological: AR101 powder provided in capsules & sachets;   Biological: Placebo powder provided in capsules & sachetsSponsor:   Aimmune Therapeutics, Inc.Recruiting – verified December 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Conditions:   Asthma;   Elevated Blood EosinophilsInterventions:   Drug: Reslizumab;   Drug: PlaceboSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified July 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

Condition:   AsthmaInterventions:   Drug: BHT 0.1%;   Drug: BHT 0.5%;   Drug: Placebo for RMT-B;   Drug: Placebo for HFA-MDISponsor:   Boehringer IngelheimCompleted – verified August 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Condition:   Aspirin Exacerbated Respiratory Disease (AERD)Interventions:   Drug: Ifetroban, Oral Capsule;   Drug: Placebo, Oral CapsuleSponsor:   Cumberland PharmaceuticalsActive, not recruiting – verified August 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses” in Healthy Volunteers.

Condition:   AsthmaInterventions:   Drug: PBF-680;   Drug: PlaceboSponsors:   Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau;   Palo Biofarma, S.LRecruiting – verified August 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days